Assessment of the association hormone replacement therapy (HRT)/denoxumab in patients whose bone mineral density not respond to treatment of simultaneous HRT/bisphosphonates

Javier Haya-Palazuelos1, Camil Castelo-Branco2,3, Maria J. Cancelo-Hidalgo4,5, Santiago Palacios6, Manel Ciria-Recasens7, Antonio Fernandez-Pareja8, Jose Manasanch-Dalmau9,∗ 1 Hospital General Universitario de Ciudad Real, Ciudad Real, Spain 2 Institut Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic, Barcelona, Spain 3 Institut dInvestigacions Biomediques August Pi i Sunyer (IDIBAPS), Faculty of Medicine University of Barcelona, Barcelona, Spain 4 Hospital Universitario de Guadalajara, Guadalajara, Spain 5 Universidad de Alcala, Alcala de Henares, Spain 6 Palacios Institute of Woman’s Health, Madrid, Spain 7 Reumatology Department Parc de Salut Mar. Hospital Universitari del Mar, Barcelona, Spain 8 CMS Hortaleza, Madrid, Spain 9 Pierre Fabre Iberica, Barcelona, Spain